Molsidomine: alternative approaches to treat myocardial ischemia.


The long-acting antianginal drug molsidomine has been shown experimentally to reduce myocardial infarct size when administered prior to or after cardiac insult. This is due to several drug actions. Dilation of postcapillary capacitance vessels diminishes venous return, preload, heart dimensions, and myocardial oxygen consumption. Relaxation of stenosed… (More)


Cite this paper

@article{Nitz1987MolsidomineAA, title={Molsidomine: alternative approaches to treat myocardial ischemia.}, author={Rebecca Nitz and Volker B. Fiedler}, journal={Pharmacotherapy}, year={1987}, volume={7 1}, pages={28-37} }